Related Experiment Video
Updated: Feb 17, 2026
08:45
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
2.4K
Paediatric age-dependent serum transferrin isoform distribution studied by HPLC
Torsten Arndt1, Sven Stanzel, Adrian C Sewell
1Bioscientia Institut fuer Medizinische Diagnostik GmbH, 55218 Ingelheim, Germany. torsten.arndt@bioscientia.de
Clinical Laboratory
|February 9, 2008
Summary
Transferrin isoforms in children show age-dependent changes, with pentasialotransferrin decreasing with age. Asialo- and monosialotransferrin are considered abnormal in pediatric serum.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Pediatric Medicine
Background:
- Human serum transferrin exists in various isoforms based on glycosylation levels, ranging from asialo- to octasialotransferrin.
- Understanding age-dependent variations in transferrin isoform distribution is crucial for accurate clinical interpretation.
Purpose of the Study:
- To investigate age-dependent differences in transferrin isoform distribution in pediatric patients.
- To establish reference ranges for transferrin isoforms in children.
Main Methods:
- Serum samples from 126 pediatric patients across seven age groups were analyzed using High-Performance Liquid Chromatography (HPLC).
- Statistical analysis, including calculation of means, medians, and percentiles, was performed for each transferrin isoform to identify significant age-related differences.
Main Results:
- Carbohydrate-deficient transferrin (CDT), corresponding to disialotransferrin, showed no significant age-related differences.
- Trisialotransferrin and tetrasialotransferrin also exhibited no statistically significant age-dependent variations.
- Pentasialotransferrin demonstrated a statistically significant decrease with increasing age in pediatric serum.
Conclusions:
- Age-independent decision limits for disialotransferrin (95th percentile: 1.1%) and trisialotransferrin (95th percentile: 5.3%) are proposed for differentiating normal from elevated levels in children.
- The detection of asialotransferrin and monosialotransferrin in pediatric serum should be considered indicative of an abnormal condition.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
335
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
335
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
323
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
323
01:29Drug Dosing: Infants and Children
337
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
337
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
268
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
268
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
256
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
284
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284